Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBarr (A.G.) Regulatory News (BAG)

Share Price Information for Barr (A.G.) (BAG)

Share Price is delayed by 15 minutes
Get Live Data
618.00    5.00 (0.82%)
Bid:
617.00
Ask:
619.00
Spread: 2.00 (0.324%)
Market Cap: £685.83m
BAG Live PriceLast checked at - London Stock Exchange

Intraday Barr (A.G.) Share Chart

AGM Statement

28 May 2021 07:00

RNS Number : 1049A
Barr(A.G.) PLC
28 May 2021
 

 28 May 2021

 

A.G. BARR p.l.c.AGM Statement

 

A.G. BARR p.l.c.,"the Company", which produces and markets some of the UK's leading drinks brands, is holding its Annual General Meeting today at 12pm BST at which the following comments will be made :

 

"We are pleased to announce that trading in the year to date is in line with the Board's expectations.

 

Despite lockdown restrictions being in place across much of the first quarter, Barr Soft Drinks trading has been relatively strong since the start of the new financial year. As lockdown restrictions have eased we have seen a positive impact on both our sales volume and mix, with a shift back towards 'drink now', hospitality and leisure. Our soft drinks trading momentum has been supported by encouraging new product launches - Rubicon RAW Energy in particular achieving promising initial customer listings and consumer feedback.

While the pace and extent of the reopening of the hospitality sector varies by region, our Funkin business is already beginning to see the benefits, delivering on-trade sales that provide optimism for the sector's recovery. Across the take-home channel, the strong performance of our Funkin ready to drink cocktails during 2020 is continuing, with an increase in both customer listings and new consumers enjoying Funkin cocktails at home.

Current trading is encouraging and we have clear plans to further invest in our brands, with exciting consumer engagement and marketing activity planned across the year.

Our balance sheet remains strong and we remain committed to our plan to recommence dividend payments during the current financial year. A further update in this regard will be provided in our half year trading update in early August 2021.

Whilst there remains some uncertainty in the short term as pandemic related restrictions ease, we believe we are well placed to drive the growth of the business and remain confident in the Company's prospects for the full year."

For more information, please contact:

 

A.G. BARR 0330 390 3900 Instinctif Partners  020 7457 2010/05

Roger White, Chief Executive Justine Warren

Stuart Lorimer, Finance Director Matthew Smallwood

Next trading update - Aug 2021

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMDZGZKVNVGMZM
Date   Source Headline
26th Jul 20193:10 pmRNSClosed period repurchase programme
25th Jul 20193:37 pmRNSDirector/PDMR Shareholding
25th Jul 20197:00 amRNSTransaction in Own Shares
24th Jul 20191:52 pmRNSDirector/PDMR Shareholding - replacement
24th Jul 20191:36 pmRNSDirector/PDMR Shareholding - clarification
24th Jul 201910:44 amRNSDirector/PDMR Shareholding - replacement
24th Jul 20197:00 amRNSTransaction in Own Shares
23rd Jul 20199:38 amRNSDirector/PDMR Shareholding
23rd Jul 20199:37 amRNSDirector/PDMR Shareholding
16th Jul 20197:00 amRNSPre-close trading update
8th Jul 201911:39 amRNSDirector/PDMR Shareholding
11th Jun 20191:14 pmRNSDirector/PDMR Shareholding
11th Jun 20191:13 pmRNSDirector/PDMR Shareholding
10th Jun 201912:40 pmRNSDirector/PDMR Shareholding
10th Jun 201912:38 pmRNSDirector/PDMR Shareholding
10th Jun 201912:37 pmRNSDirector/PDMR Shareholding
10th Jun 201912:36 pmRNSDirector/PDMR Shareholding
10th Jun 201912:29 pmRNSDirector/PDMR Shareholding
7th Jun 20197:00 amRNSMinority investment in STRYYK
31st May 201912:42 pmRNSAGM Statement
29th May 20198:04 amRNSHolding(s) in Company
9th May 20193:58 pmRNSDirector/PDMR Shareholding
3rd May 20191:18 pmRNSDirector/PDMR Shareholding
17th Apr 20199:24 amRNSAnnual Report and Accounts and Notice of AGM
4th Apr 20193:25 pmRNSDirector/PDMR Shareholding
2nd Apr 20191:51 pmRNSDirector/PDMR Shareholding
2nd Apr 20191:43 pmRNSDirector/PDMR Shareholding
26th Mar 20197:00 amRNSFinal Results
8th Mar 20191:11 pmRNSDirector/PDMR Shareholding
8th Mar 20199:36 amRNSHolding(s) in Company
15th Feb 20197:30 amRNSTransaction in Own Shares
8th Feb 20199:39 amRNSDirector/PDMR Shareholding
8th Feb 20197:30 amRNSTransaction in Own Shares
5th Feb 20197:30 amRNSTransaction in Own Shares
25th Jan 201912:25 pmRNSClosed period repurchase programme
25th Jan 20197:00 amRNSTrading Update
15th Jan 201910:48 amRNSNotice of Pre-Close Trading Update
9th Jan 201912:38 pmRNSDirector/PDMR Shareholding
10th Dec 20181:32 pmRNSDirector/PDMR Shareholding
8th Nov 201812:14 pmRNSDirector/PDMR Shareholding
29th Oct 201812:26 pmRNSDirector/PDMR Shareholding
29th Oct 201812:24 pmRNSDirector/PDMR Shareholding
29th Oct 201812:22 pmRNSDirector/PDMR Shareholding
29th Oct 201812:19 pmRNSDirector/PDMR Shareholding
25th Oct 20187:00 amRNSBoard Appointment
23rd Oct 20187:30 amRNSTransaction in Own Shares
17th Oct 20187:30 amRNSTransaction in Own Shares
16th Oct 20187:30 amRNSTransaction in Own Shares
12th Oct 20187:44 amRNSTransaction in Own Shares
10th Oct 20187:30 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.